Mediliant Group Unveils New Brand Identity as They Merge and Expand Global Capabilities
The Mediliant Group has rebranded its organization to SpiTrex Orthopedics to serve its customers better and encompass a unified brand that showcases the full extent of its capabilities.
LE LOCLE, Switzerland, May 23, 2023 /PRNewswire-PRWeb/ -- In the wake of their successful merger of Mediliant SA, CTE Solutions, and MDI LLC, medical device contract manufacturing leaders, the Mediliant Group, has announced its rebrand to SpiTrex Orthopedics. The new brand reflects its mission and vision to positively impact people's lives by developing life-enhancing medical technologies.
Representing speed, precision, and industry-best lead times, SpiTrex Orthopedics' capabilities instill trust in customers within the medical device industry.
"We're extremely excited about the platform that we're building. Relaunching our brand is just the first step in what we expect to be an exciting journey of growth. It serves as notice to our customers and employees that we are one company, ready and able to serve with a complete portfolio of capabilities and locations. The values of precision, speed, and unparalleled lead times that epitomize our brand are a testament to our unwavering dedication to providing exceptional customer service. We want to build lean and robust supply chains that offer unquestionable reliability; to help our customers be first to market with rapid prototyping and new product launches; and we want to be the first to respond when our customers call with a need." - Matt Burba, CEO of SpiTrex Orthopedics.
"SpiTrex Orthopedics represents the next step in our growth and development. With exciting acquisitions poised to join us, adding even more capacity and new capabilities, we're making big strides in our desire to be the premier CMO in Spine, Trauma and Extremities. The rebrand has been an exciting journey, made even better since our new name came from one of our valued employees." added Rob Debney, Senior Vice-President of Sales and Marketing
Driven by the commitment to enhance the customer experience with a relentless dedication to perfection, SpiTex Orthopedics aims to positively impact patient lives through its production quality, speed, and manufacturing expertise.
The international contract manufacturer specifically focuses on complex orthopedic implants for the Spine, Extremity, and Trauma markets. Their multi-site footprint currently consists of three manufacturing locations in Plymouth, IN, Lancaster, PA, and Le Locle, Switzerland, though new sites and capabilities will be added this year.
The organization's unique philosophy is reflected through its core purpose, Improving Lives, Together, clarifying its dedication to unity and collaboration between customers, partners, and its experts as they continue their expansion worldwide.
SpiTrex Orthopedics will showcase its new brand at this year's OMTEC conference in Chicago from June 13th to 15th at booth #250.
To learn more, visit their new website, spitrexorthopedics.com
About SpiTrex Orthopedics
SpiTrex Orthopedics is dedicated to being a partner in manufacturing medical devices with a focus on Improving Lives, Together. They believe that together they can positively impact lives, that success comes from integrity, serving others, and a relentless quest for perfection, and that all problems can be solved with dedication, creative thinking, and personal care.
ROB DEBNEY, Mediliant Group, 44 7551 156697, firstname.lastname@example.org
SOURCE Mediliant Group
Upcoming Life Sciences Events
- June 2023
- Boston: Product & Company Valuation Course
- BIO International Convention 2023
- RESI Boston
Latest company news
Public advisory - Unauthorized amoxicillin capsules seized from Green Fresh Supermarket in Ottawa, ON, may pose serious health risks
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) receives CHMP positive opinion for expanded use in children and adolescents with growth hormone deficiency
Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023